Martijn Kedde

2.6k total citations · 2 hit papers
17 papers, 2.1k citations indexed

About

Martijn Kedde is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Martijn Kedde has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Martijn Kedde's work include RNA modifications and cancer (6 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Martijn Kedde is often cited by papers focused on RNA modifications and cancer (6 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Martijn Kedde collaborates with scholars based in Netherlands, United States and Denmark. Martijn Kedde's co-authors include Reuven Agami, Marieke van Kouwenhove, Carlos le Sage, Anja Duursma, Joachim A.F. Oude Vrielink, Mariëtte Schrier, Wilbert Zwart, Ran Elkon, Erez Raz and Remco Nagel and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature reviews. Cancer.

In The Last Decade

Martijn Kedde

16 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA

2007 591 citations Martijn Kedde, Bijan Boldajipour et al. Cell profile →
MicroRNA regulation by RNA-binding proteins and its implications for cancer

2011 507 citations Marieke van Kouwenhove, Martijn Kedde et al. Nature reviews. Cancer profile →

Peers

Martijn Kedde

GENET

IMMUN

ONCOL

Joachim A.F. Oude Vrielink Netherlands

Katherine McJunkin United States

Kaitlyn A. Webster United States

Chryssa Kanellopoulou United States

Frédéric Koch Germany

Karim Malik United Kingdom

Lasse Weinmann Germany

Stephen M. Lewis Canada

Jill Magnus United States

Monica Ballarino Italy

Joachim A.F. Oude Vrielink Netherlands

Martijn Kedde

2.2k ×1.2

1.2k ×1.0

168 ×1.0

GENET

69 ×0.6

IMMUN

170 ×1.6

ONCOL

Citations per year, relative to Martijn Kedde Martijn Kedde (= 1×) peers Joachim A.F. Oude Vrielink

Countries citing papers authored by Martijn Kedde

Since Specialization

Citations

This map shows the geographic impact of Martijn Kedde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martijn Kedde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martijn Kedde more than expected).

Fields of papers citing papers by Martijn Kedde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martijn Kedde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martijn Kedde. The network helps show where Martijn Kedde may publish in the future.

Co-authorship network of co-authors of Martijn Kedde

This figure shows the co-authorship network connecting the top 25 collaborators of Martijn Kedde. A scholar is included among the top collaborators of Martijn Kedde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martijn Kedde. Martijn Kedde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kedde, Martijn, Vanessa Clerico Mosina, Bradley R. Pieters, et al.. (2025). 17P KBA1413: An antibody derived from a cured AML patient, recognizes a unique glycoepitope shared by AML, MDS and several solid cancer cells. ESMO Open. 10. 104173–104173. 1 indexed citations

Schotte, Remko, Julien Villaudy, Martijn Kedde, et al.. (2020). 580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection. Annals of Oncology. 31. S492–S492. 1 indexed citations

Kedde, Martijn, Els M.E. Verdegaal, Etsuko Yasuda, et al.. (2020). Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo. Cancer Immunology Immunotherapy. 70(6). 1569–1581. 9 indexed citations

Villaudy, Julien, Remko Schotte, Wouter Pos, et al.. (2020). 582P Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL. Annals of Oncology. 31. S493–S493. 3 indexed citations

Kedde, Martijn, Els M.E. Verdegaal, Etsuko Yasuda, et al.. (2019). PS971 AT1413 ANTIBODY DERIVED FROM A CURED AML PATIENT RECOGNIZES A UNIQUE CD43 EPITOPE SHARED BY AML, MDS AND MELANOMA AND HAS IN VIVO ACTIVITY AS UNMODIFIED ANTIBODY AND AS BISPECIFIC T CELL ENGAGER. HemaSphere. 3(S1). 437–438. 1 indexed citations

Kedde, Martijn, Gemma Moiset, Etsuko Yasuda, et al.. (2017). AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses. Blood. 131(1). 131–143. 16 indexed citations

Kedde, Martijn, Etsuko Yasuda, Gemma Moiset, et al.. (2017). Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice. Blood Advances. 1(19). 1551–1564. 22 indexed citations

Kedde, Martijn, Etsuko Yasuda, Arjen Q. Bakker, et al.. (2016). Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Blood. 128(22). 1646–1646. 2 indexed citations

Kedde, Martijn, Etsuko Yasuda, Arjen Q. Bakker, et al.. (2016). Abstract A026: Tumor-specific glycosylated CD43 is a novel and highly specific target for acute myeloid leukemia and myelodysplastic syndrome. Cancer Immunology Research. 4(11_Supplement). A026–A026. 1 indexed citations

10.

Kedde, Martijn, Etsuko Yasuda, Arjen Q. Bakker, et al.. (2015). Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity. Blood. 126(23). 3146–3146. 1 indexed citations

11.

Kouwenhove, Marieke van, Martijn Kedde, & Reuven Agami. (2011). MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nature reviews. Cancer. 11(9). 644–656. 507 indexed citations breakdown →

12.

Kedde, Martijn, Marieke van Kouwenhove, Wilbert Zwart, et al.. (2010). A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility. Nature Cell Biology. 12(10). 1014–1020. 326 indexed citations

13.

Agami, Reuven, et al.. (2010). 24 Cancerous microRNAs and regulatory RNA binding proteins. European Journal of Cancer Supplements. 8(5). 7–7. 1 indexed citations

14.

Duursma, Anja, Martijn Kedde, Mariëtte Schrier, Carlos le Sage, & Reuven Agami. (2008). miR-148 targets human DNMT3b protein coding region. RNA. 14(5). 872–877. 448 indexed citations

15.

Kedde, Martijn & Reuven Agami. (2008). Interplay between microRNAs and RNA-binding proteins determines developmental processes. Cell Cycle. 7(7). 899–903. 105 indexed citations

16.

Kedde, Martijn, Bijan Boldajipour, Joachim A.F. Oude Vrielink, et al.. (2007). RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA. Cell. 131(7). 1273–1286. 591 indexed citations breakdown →

17.

Kedde, Martijn, Carlos le Sage, Anja Duursma, et al.. (2006). Telomerase-independent Regulation of ATR by Human Telomerase RNA. Journal of Biological Chemistry. 281(52). 40503–40514. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact